Skip to main content
Back
Watch Compare

RenovoRx, Inc.

Data quality: 100%
RNXT
Nasdaq Manufacturing Chemicals
$0.99
▲ $0.05 (5.43%)
Mkt Cap: 46.81 M
Price
$0.99
Mkt Cap
46.81 M
Day Range
$0.92 — $1.01
52-Week Range
$0.70 — $1.45
Volume
262,140
Open $0.92
50D / 200D Avg
$0.95
4.06% above
50D / 200D Avg
$1.07
7.04% below

Quick Summary

Key Takeaways

Negative free cash flow of -10.98 M
Capital efficient — spends only 0.18% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)2511.63%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-119.32%
Below sector avg (-53.41%)
ROIC-92.32%
Net Margin-994.48%
Op. Margin-1113.98%

Safety

Debt / Equity
N/A
Current Ratio5.83
Interest CoverageN/A

Valuation

PE (TTM)
-4.19
Below sector avg (-1.48)
P/B Ratio5.79
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -4.2 -1.5
P/B 5.8 1.6
ROE % -119.3 -53.4
Net Margin % -994.5 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2511.63% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.12 M Net Income (TTM) -11.17 M
ROE -119.32% ROA -89.89%
Gross Margin 70.88% Operating Margin -1113.98%
Net Margin -994.48% Free Cash Flow (TTM) -10.98 M
ROIC -92.32% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.83
Interest Coverage N/A Asset Turnover 0.09
Working Capital 9.10 M Tangible Book Value 8.08 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.19 Forward P/E N/A
P/B Ratio 5.79 P/S Ratio 41.68
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.45%
Market Cap 46.81 M Enterprise Value 36.77 M
Per Share
EPS (Diluted TTM) -0.32 Revenue / Share 0.02
FCF / Share -0.23 OCF / Share -0.23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.18% FCF Conversion 98.27%
SBC-Adj. FCF -12.21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.12 M 43,000.0 — — —
Net Income -11.17 M -8.81 M -10.23 M -9.89 M -6.32 M
EPS (Diluted) -0.32 -0.40 -0.99 — —
Gross Profit 796,000.0 43,000.0 — — —
Operating Income -12.51 M -10.97 M -11.40 M -9.95 M -5.67 M
EBITDA — — — — —
R&D Expenses 6.27 M 6.03 M 5.67 M 4.30 M 3.04 M
SG&A Expenses 7.04 M 4.99 M — — —
D&A 2.00 M — — — —
Interest Expense — — — — -834,000.0
Income Tax 2,000.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.10 M 8.12 M 1.47 M 7.27 M 16.29 M
Total Liabilities 2.67 M 3.64 M 4.47 M 1.10 M 938,000.0
Shareholders' Equity 5.42 M 4.48 M -3.00 M 6.16 M 15.35 M
Total Debt — — — — —
Cash & Equivalents 7.02 M 7.15 M 1.17 M 4.39 M 15.19 M
Current Assets 7.89 M 7.83 M — 7.27 M 16.28 M
Current Liabilities 1.96 M 1.91 M 1.18 M — 938,000.0